MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2020 Financial Results

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release fourth quarter financial results for the three and twelve month period ended December 31, 2020 before markets open on Wednesday, March 31, 2021.

MediPharm Labs executive management team will also host a conference call and audio webcast on Wednesday March 31, 2021, at 8:30 a.m. eastern time to discuss the Company’s financial results and outlook.

Audio Conference Call Dial in Details:

Toll-free number: [phone] / International number: [phone] / Conference ID: 5076026

Participants are asked to dial in approximately 15 minutes before the start of the call.

Audio Webcast:

An audio webcast will be available in the Events section of the MediPharm Labs’ Investor Relations website https://ir.medipharmlabs.com/news-events or by visiting the following link here.

For those who are unable to participate on the live conference call and webcast, a replay will be available approximately one hour after completion of the call.

A replay of the audio webcast will be available after the call has ended until April 7, 2021 11:59 p.m. eastern time. Within North America dial [phone] or International dial [phone] outside North America using Conference ID: 5076026.

About MediPharm Labs Corp.

Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard built clean rooms. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision -dosed cannabis products for its customers. Through its wholesale and white label platforms, they formulate, consumer-test, process, package and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and has fully commercialized its wholly-owned Australian extraction facility. MediPharm Labs Australia was established in 2017.